Induced pluripotent stem (iPS) cells are a type of undifferentiated cell that can be obtained from differentiated cells and have the pluripotent potential to differentiate into the musculoskeletal system, the myocardium, vascular endothelial cells, neurons, and hepatocytes. We therefore cultured mouse iPS cells in a DMEM containing 15% FBS, 10 −7 M dexamethasone, 10 mM β-glycerophosphate, and 50 µg/ml ascorbic acid for 3 weeks, in order to induce bone differentiation, and studied the expression of the bone differentiation markers Runx2 and osteocalcin using RT-PCR in a time-dependent manner. Osteocalcin, a bone differentiation marker in bone formation, exhibited the highest expression in the third week. In addition, the deposition of calcium nodules was observed using Alizarin red S staining. iPS cells cultured for bone differentiation were transplanted into severe combined immunodeficiency (SCID) mice, and the osteogenic potential exhibited after 4 weeks was studied. When bone differentiation-induced iPS cells were transplanted into SCID mice, bone formation was confirmed in soft X-ray images and tissue specimens. However, teratoma formation was confirmed in 20% of the transplanted models. When mouse iPS cells were treated with irradiation of 2 Gray (Gy) prior to transplantation, teratoma formation was inhibited. When mouse iPS cells treated in a likewise manner were xenotransplanted into rats, bone formation was confirmed but teratoma formation was not observed. It is believed that irradiation before transplantation is an effective way to inhibit teratoma formation.
INTRODUCTION
In the field of orthopedics, many materials (e.g., autobone graft, allobone graft, artificial bone, or sometimes bone cement) are used as bone fill in significant bone Induced pluripotent stem (iPS) cells are undifferentiated cells induced from differentiated cells with genetic defect that results from aging, disease, or trauma. The purpose of bone fill is to augment bone intensity and to and morphological characteristics equal to those derived from embryonic stem (ES) cells (32). They have the increase the regenerative potential around the bone defect. Autobone graft has the best property for bone fill potential to differentiate into various cells in vitro (13) . Recent studies have demonstrated that ES cells cultured (8), although there are downsides such as a limited bone harvest and invasion associated with bone harvest (3) . in an appropriate environment differentiate into osteogenic cells (5) . As such, it is expected that the potential Allobone graft has a risk of infection and its osteoinductive potential is limited because osteogenic cells inside use of iPS cells will increase by differentiating them into various cells for regenerative purposes.
it are killed by treatments before transplantation. Almost 592 HAYASHI ET AL.
all artificial bones are ceramics, which have enough cultures. Nodular cell clumps in suspension cultures were confirmed. strength as bone fill. Therefore, they have no osteoinductive properties by themselves. In order to increase Osteogenic Induction by Culturing their bone-regenerative potentials, various cells and in Osteogenic Medium growth factors, such as mesenchymal stem cells (MSCs), osteoblasts, bone morphogenic protein, etc., After EB formation for 5 days, trypsinized EB cells were seeded on gelatine-coated six-well culture plates at were used with them. If creation were possible from autologous cells and clumps of cells that can facilitate a density of 1 × 10 5 cells/well and were started culturing in osteogenic medium. The osteogenic medium was bone formation or that can fill the bone void, it would surely expand the scope of regenerative medicine in the DMEM supplemented with 10% fetal bovine serum, 10 nM dexamethasone, 50 mg/L ascorbic acid (Wako, field of orthopedics.
We decided to study bone differentiation potential Osaka, Japan), 10 mM β-glycerophosphate (Sigma-Aldrich, Tokyo, Japan), 50 U/ml penicillin, and 50 mg/ml strep-using mouse iPS cells. However, the problem with iPS cells with high differentiation potential is that they form tomycin (Sigma-Aldrich) as previously described (31) . The medium was changed every 3 or 4 days. teratomas after being transplanted in vitro (35). It is quite important to develop effective ways to induce bone
The Potential of Creating Calcium Nodules differentiation and, at the same, develop techniques to of iPS Cells In Vitro prevent teratomas. This time, we studied the bone differentiation of mouse iPS cells in vitro and conducted an On the 14th and 21st days of osteogenic induction, Alizarin red staining was performed. After 70% ethanol evaluation of bone regeneration and the frequency of occurrence of teratomas by transplanting bone differenti-fixation for 10 min, they were washed in distilled water (DW) two times and absolute ethanol was added to ation-induced iPS cells into mouse models with calvarial defects. We also studied the effect of xenotransplanta-remove water. They were stained with a 1% solution of pH 4.2 conditioned Alizarin Red S (Nacalai Tesque) for tion of mouse iPS cells into Wistar rat models with calvarial defects.
2 min. Excess stain was washed off in tap water and the cultures were then air-dried. More than 10 photographs MATERIALS AND METHODS of each sample were taken using a phase-contrast micro-iPS Cell Culture scope. The red staining area that contained calcium nodules was measured by Image-J. We used mouse iPS cells of 10th passage supplied by Kyoto University (Cell No. APS0001, Cell name
The Expression of Bone-Related Genes iPS-MEF-Ng-20D-17, Lot No. 006), which we purof iPS Cells In Vitro chased from RIKEN. They were cultured on mitomycin On the 7th, 14th, and 21st days, according to the pro-C (BIOMOL, PA, USA)-treated SNL cells (DS Pharma cedure, total RNA was extracted using RNasey easy Biomedical, Osaka, Japan) used as feeder cells. Dulbecmini Kit (QIAGEN Science, Tokyo, Japan) and RT-PCR co's modified Eagle medium (DMEM; Nacalai Tesque, was performed with i-cyclor (Bio-Rad, Tokyo, Japan) to Kyoto, Japan) adding 15% fetal bovine serum (FBS) study the expression of runt-related transcription factor (Gibco), 50 U/ml penicillin and 50 mg/ml streptomycin 2 (Runx2) and osteocalcin. One microgram of total RNA (Invitrogen), 2 mM L-glutamine (Invitrogen), 1 × 10 −4 was transcripted with River-Tra Ace (Toyobo, Tokyo, nonessential amino acids (NEAA) (Invitrogen), and 1 × Japan), oligo(dT)20 (Toyobo), RNase inhibitor (Toyobo), 10 −4 M 2-mercaptoethanol (Invitrogen) was used. The 5× RT buffer (Toyobo), and dNTP mixture (Toyobo). medium was changed every 1 or 2 days. The passage of cDNA was amplified with Takara Taq (Mg 2+ plus Buffer) iPS cells was performed every 3 days. All subcultures (TaKaRa, Ootsu, Japan), 10× PCR buffer (TaKaRa), and were performed in a 37°C incubator with 5% CO 2 .
dNTP mixture (TaKaRa). After a single incubation at Osteogenic Induction of iPS Cells 94°C for 5 min to activate the polymerase enzyme, samples were run at the following setting: 94°C for 30 s, Our protocol of osteogenic differentiation of iPS cells 60°C for 30 s, followed by 72°C for 30 s for a total of was two staged (Fig. 1 ). The first stage was the forma-30 cycles; and final elongation at 72°C for 7 min. The tion of embryoid bodies (EB) and the second stage was PCR analysis was conducted with the following primers: the culturing in osteogenic medium.
Runx2, sense strands 5′-agaaggcacagacagaagc-3′ and EB Formation by iPS Cells antisense strands 5′-ctggaagggtccactctg-3′; osteocalcin, sense strands 5′-ttctgctcactctgctgacc-3′ and antisense For effective induction, iPS cells were seeded on an ultralow attachment six-well plate at a density of 1 × 10 5 strands 5′-accttattgccctcctgctt-3′; glyceraldehyde 3-phosphate dehydrogenase (GAPDH), sense strands 5′-tgcac cells per well and were grown for 5 days in suspension 
caccaactgcttagc-3′ and antisense strands 5′-ggcatggactgt Two Bone Defect Models ggtcatgag-3′). Electrophoresis of PCR was done with
In order to examine whether iPS cells induce bone ethidium bromide with added 2% agarose gel. formation, two different bone defect models were prepared. Eight-week-old adult SCID mice (Nippon CLEA,
Irradiation of iPS Cells
Tokyo, Japan) and 10-week-old Wister rats (Nippon In order to inhibit teratoma formation by iPS cells CLEA, Tokyo, Japan) were used. A critical calvarial transplanted into models with calvarial defects, iPS cells bone defect model was used as previously described in were irradiated after being bone differentiated. Irradiadetail (7). Under general anesthesia, the scalp was tion was performed at the irradiation facility attached opened sharply transversely to midline to expose the calto the animal control center using MBR-1520R (Hitachi varia. Periosteal tissue over the parietal bone was Medico, Tokyo, Japan). iPS cells, plated on a gelatinremoved. Two calvarial defects of 3 mm diameter for coated six-well culture plate at a density of 5 × 10 5 cells/ mouse and 5 mm diameter for rat were made in both well to induce bone differentiation for 3 weeks, were parietal bones with diamond-bit H-282 (Sunflex, Osaka, irradiated with doses of 1, 2, and 4 Gy, in order to study Japan) revolving by Joy-Robo Pro H-027 (Sunflex, cell viability by thiazolyl blue tetrazolium bromide Osaka, Japan), as we conducted previously (26). The (MTT) assay. The expression of bone-related genes was bone defects were washed with saline to remove bone assessed by RT-PCR 1 week after radiation treatment.
powders and blood, and then transplanted samples. After the cell transplantation, the skin was sutured with 4-0 In Vivo Transplantation Experiments nylon sutures. All experiments were performed in accordance with Cell Transplantation to Bone Defects Okayama University ethical committee and were conducted at Okayama University Animal Control Center After EB formation, mouse iPS cells were divided into the following three groups and cultured in the dif-in compliance with the Guidelines for Proper Conduct of Animal Experiments. ferent conditions for the transplantation experiment.
Group 1 (G1): iPS cells cultured in regular medium. iPS RESULTS cells were plated on a gelatin-coated six-well culture
In Vitro Potential of iPS Cells to Induce Bone plate at a density of 1 × 10 5 cells per well to create a Differentiation further 21-day culture in the regular medium without Bone differentiation was induced for iPS cells for 3 growth factors, DMEM with added 10% FBS, 50 U/ml weeks and then the cells were irradiated with doses of penicillin, and 50 mg/ml streptomycin. Group 2 (G2):
1, 2, and 4 Gy. The MTT assay was performed for iPS iPS cells cultured in osteogenic medium. iPS cells were cell viability 3 days after irradiation. The MTT values plated on a gelatin-coated six-well culture plate at a denwere 0.63 ± 0.11 for 1 Gy, 0.52 ± 0.03 for 2 Gy, and sity of 1 × 10 5 cells/well and cultured for 21 days in an 0.31 ± 0.06 for 4 Gy. Irradiation of 4 Gy markedly osteoinductive medium. Group 3 (G3): irradiated iPS induced cell injury. cells after osteogenic differentiation. Induction of bone
The extent of calcium nodule formation by iPS cells differentiation was carried out as with group 2, followed during bone differentiation induction was studied using by irradiation with doses of 2 Gy.
Alizarin red staining. The rate of staining in calcium Examination of the Osteogenic Potential of iPS Cells nodules was 10 ± 3% in the first week of bone differen-Using Mouse Models With Calvarial Defects tiation induction, 40 ± 3% in the second week, and 80 ± In order to make it easier to compare the bone forma-3% in the third week, thereby demonstrating an increase tion between groups, two different groups of cells were in the number of calcified nodules in a time-dependent transplanted to each bone defect (G1 vs. G2, G1 vs. G3, manner. The rate of staining in calcium nodules was 85 and G2 vs. G3). The number of transplanted cells was ± 5% in cases in which irradiation was performed after 1 × 10 6 cells per defect. Five models for each comparithe third week of bone differentiation induction ( Fig. 2 ). son were made and therefore 10 specimens for each This was comparable to the results of the nonirradiation group were analyzed.
cases. Gene expression of the bone differentiation induction markers Runx2 and osteocalcin, shown by RT-PCR, Xenotransplantation of iPS Cells Using Rat Models confirmed the expression of Runx2, an initial stage With Calvarial Defects marker of osteoblast differentiation, and the expression The main purpose of this experiment was to study the of osteocalcin, late stage markers of osteoblast differenprevention of teratoma formation of mouse iPS cells by tiation. Following confirmation of the enforced expresradiation treatment and subsequent xenotransplantation. sion of an initial stage marker Runx2, the expression Irradiated iPS cells (3 × 10 6 ) after osteogenic differentiaof osteocalcin, which demonstrates differentiation into tion (G3 cells, as mentioned above) were transplanted osteoblasts, increased in a time-dependent manner (Fig. 3 ). into the left side of calvarial defects (5 mm diameter) in rats. The defect in the right side was irrigated by PBS Transplantation of Bone Differentiation-Induced containing no cells and served as a control.
iPS Cells Facilitates Regeneration Radiological and Histological Examination in Mouse Models of Calvarial Defects At 4 weeks following transplantation, in order to Soft X-ray images demonstrated new bone formation evaluate bone defects, models were given an overdose in bone defects in the group of models with transplantaof anesthesia before their skulls were extracted for soft tion of bone differentiation induced iPS cells (G2 and X-ray radiographs using Softex type CMB (Softex, G3) ( Fig. 4A ). Recovery of bone defects was signifi-Tokyo, Japan). Having been fixed in 4% formaldehyde cantly better in this group than in the group of models for 24 h, the extracted skulls were placed in ethylenediwith transplantation of iPS cells that had not undergone amine tetraacetic acid (EDTA) for 7 days for demineralbone differentiation induction (G1) (G1 vs. G2, p = ization, then wrapped in paraffin, and thinly sectioned 0.046; G1 vs. G3, p = 0.040; G2 vs. G3, p = 0.839) ( Fig.  at 6 µm for hematoxylin and eosin (H&E) staining. 4B). H&E staining also showed, in the group of models Bone density inside bone defect was measured using with transplantation of bone differentiation-induced iPS Image-J. First, we measured the density of normal corticells, new bone formation not only in the periphery of cal bones as a control. Then the density inside of defects the bone defects but also in the center (Fig. 5 ). On the was compared with control. Teratoma formation was other hand, in the group of models with transplantation confirmed by histological findings.
iPS cells that had not undergone bone differentiation Statistical Analysis induction (G1), although bone formation was observed in the periphery of the bone defects, bone formation in The t-test was used to statistically process the mean value. Multiple comparisons were performed by Bonfer-the centre was found to be insufficient (Fig. 5) . Further, the expression of Runx2 and osteocalcin shown by RT-roni test. A value of p < 0.05 was set as an indication of significant difference.
PCR was significantly higher in the group of models with transplantation of bone differentiation induced iPS were irradiated with dose of 2 Gy, bone formation was induced without teratoma formation (Fig. 7) . cells. However, tumor formation was visually observed in both G1 and G2 (Fig. 6 ). The results from H&E stain-DISCUSSION ing demonstrated that these tumors consisted of pseudoglandular, dermoid, and chondroid structures; in other Tissues are formed from mature stem cells and precursor cells. In recent years, studies have been actively words, teratomas differentiated into triploblastic cells.
conducted in order to make use of pluripotent stem cells Xenotransplantation Using Bone for bone regeneration and, with regard to bone regenera-Differentiation-Induced Mouse iPS Cells tion, studies have been conducted using ES cells (16) and bone marrow MSCs (29) . In particular, differentia-Bone differentiation-induced mouse iPS cells were transplanted into 12-week-old Wistar rats (n = 3), at 1 × tion of MSCs is comparatively easy to regulate and these cells are thus being applied clinically. In this context, 10 6 cells each, that were then observed for 4 weeks. In the group of models with transplantation of iPS cells the study and application of these cells may be more advanced in the field of bone regeneration than other that had undergone bone differentiation induction and The gene expression of runt-related transcription factor 2 (Runx2), an initial stage marker of bone differentiation, was confirmed. The expression of osteocalcin, an osteoblast expression marker, increased in a time-dependent manner. The value of Runx2, an initial stage marker of bone differentiation, was highest in the first week, and gradually decreased thereafter. Comparison between the irradiation group and the nonirradiation group found no differences after the third week of bone differentiation. Glyceraldehyde 3-phospahte dehydrogenase (GAPDH) was used as a control. types of cells (25) . However, one of the major problems factors into mouse mature fibroblasts (33). In 2007, it was demonstrated that iPS cells could also be created associated with mesenchymal stem cells is the fact that there is a limit to the proliferative capacity of its popula-using human cells, thereby substantially raising expectations for future clinical use in regenerative medicine (32). tions and that they become senescent (4) . We therefore tried to create an in vitro a cell line that could proliferate iPS cells, with high proliferative capacity of its populations as ES cells, can be created from the distal cells indefinitely by introducing telomerase genes into MSCs (26). Progress in cell biology has made it possible to of each individual and thus offer an advantage of enabling cell transplantation that does not require administration initialize mature cells. It was reported in 2006 that iPS cells could be created by introducing four transcription of immunosuppressant (10). As iPS can be created from Figure 5 . Histological evaluation of new bones by way of transplantation of iPS cells into mouse models with calvarial defectsIn G1, bone differentiation was not performed, and new bone formation was not observed following cell transplantation. Massive tumor was observed and this tumor confirmed to be teratoma histologically. In this series, teratoma formation at a rate of 40% was observed. After the transplantation of bone differentiation induced iPS cells (G2), new bone formation was observed, but at the same time teratoma formation was also observed. In G3 where bone differentiation induced and irradiated iPS cells were transplanted, new bone formation comparative to that in G2 was observed, without teratoma formation being detected (G1: iPS cells that were not bone differentiation induced; G2: bone differentiation induced iPS cells; G3: iPS cells that were bone differentiation induced and irradiated). The arrow indicates cells and the range of calvarial defects. Scale bars: 1 mm.
Figure 6.
Potential of iPS cells to form teratomas. In the nonirradiated groups (G1 and G2; n = 10) as both groups show tumors. On the other hand, in the irradiation group (G3, n = 10), no teratoma formation was observed in any of the models. A typical example of these findings is shown (G1: iPS cells that were not bone differentiation induced; G2: bone differentiation induced iPS cells; G3: iPS cells that were bone differentiation induced and irradiated). Scale bars: 10 mm.
the patient's own cells, once a method to differentiate has no osteogenetic potentials in itself. Many growth factors like bone morphogenetic protein-2 (BMP-2) (17) them into envisaged organs has been established, it becomes possible to avoid rejection of the transplant. and connective tissue growth factor (CTGF) (15) and cells like osteoblasts and MSCs (20) are used with them This would be a major breakthrough for its application in both transplantation and regenerative medicine.
to enhance a bone regenerative capacity. However, there have been few studies reported on bone regeneration The actual application of regenerative medicine in the field of orthopedics has taken a form of a tissue-engi-using iPS cells (6). Against this background, this time we studied bone regeneration using mouse iPS cells. neered ceramic artificial bone (19). The artificial bone As iPS cells have biological features similar to that observation after transplantation. With regard to irradiation of 2 Gy, the expression of genes closely related to of ES cells, it was decided that induction of bone differentiation of ES cells should be applied in this study. The osteoblasts was maintained, and after the transplantation, efficient bone regeneration was histologically con-cells themselves were not genetically engineered and their differentiation was inducted using the addition of firmed. In terms of irradiation doses, the irradiation of 4 Gy substantially decreased the bone differentiation liquidity factors including dexamethasone, ascorbic acid, and β-glycerophosphate (31) . This method only requires induction activity of iPS cells. In this examination, it was considered that irradiation of 2 Gy may be an effec-that these liquidity factors be added into cell culture fluids, and is thus a simple procedure from which results tive method. In the examination of xenogenic cell transplantation in rats performed in our study, no teratoma with high reproducibility can be obtained. This method will also enable automated cell cultures in the future.
formation of mouse iPS cells was observed, suggesting its potential efficacy in preventing teratoma formation. As a result, Alizarin red staining revealed a number of calcified nodules and demonstrated that bone minerals This time, it is likely that our report is the first report demonstrating that no teratoma formation was observed had been induced (23) . Furthermore, the expression of Runx2, an initial stage marker of osteoblast differentia-in allogeneic transplantation and xenotransplantation of iPS cells that are bone differentiated and irradiated. The tion (11), and the expression of osteocalcin, late stage markers of bone differentiation (22), were observed. molecular biological mechanism action of differentiation-induced iPS cells is currently being examined. In However, in the group of models for transplantation of iPS-derived osteoblasts obtained in this method, good general, as an effect of the radiation itself, various signals inside the cell are transmitted as a result of the radi-bone regeneration was obtained, but at the same time, teratoma formation was confirmed. ation stress response inside the cell (30) . The well-known pathway is that with emphasis on the role of p53 (21) . Important issues in clinical cell transplantation that need to be resolved are the control of rejection and the As a result, cells die when the cell cycle is blocked. It is believed that, in an undifferentiated state, in other prevention of tumor formation, including formation of teratomas (35). Tumor formation associated with trans-words when cells are very active, teratoma formation tends to take place. It is believed that, treated with irra-plantation must always be avoided when the procedure is used in humans. With regard to the occurrence of diation, and due to the DNA damage as a result thereof, phosphorylation of specific proteins occurs, which in malignant tumors, the involvement of c-Myc introduced at the time of the generation of iPS cells has been turn initiates a series of intracellular signal transduction pathways, thereby inhibiting the expression of genes reported, but the involvement of c-Myc has not been reported in relation to teratomas (12). Also, no report necessary for cell cycle progression. Specifically, it is known that a mechanism exists to block progression has been made that other genes are directly involved (24) . Although the incidence of teratomas after the sub-from the G 1 phase to the S phase and from the G 2 phase to the M phase (27) . This time, in our study, iPS cells cutaneous transplantation of ES cells for the purposes of examining the undifferentiation potential of ES cells to were irradiated, and although the duration of follow-up observation after the transplantation was up to 4 weeks, SCID mice is said to be 25-100% (28), long-term follow-ups may find the incidence of teratomas even no teratoma formation was observed. It has been reported that no teratoma formation was observed of iPS higher. In regard to the number of cells to be transplanted, it has been reported that 5 × 10 5 or more cells cells created from mice that had received resveratrol (14) . The possibility has been demonstrated that resvera-would be necessary for ES cell teratoma formation (18). The incidence of teratoma formation was reported trol would lower the level of undifferentiation of iPS cells, thereby inhibiting teratoma formation. higher in iPS cells than ES cells (9).
Inevitably, in this study, a high incidence of teratoma With regard to the inhibition of teratoma formation after cell transplantation, it has been reported that, for formation was expected after the transplantation of iPSderived osteoblasts into SCID mice without self-immu-cases in which iPS cells had been created from hepatocytes and gastric parietal cells at the cell creation stage nity. In this examination, teratoma formation was seen at a rate of 40% during the 4-week follow-up observa-(1), there was less tumor formation by these cells with the decreased level of reactivation of retrovirally intro-tion in the group of models with transplantation of nonirradiated iPS cells that underwent bone differentiation. duced c-Myc (2) . The usage of these cells and resveratrol may reduce the potential to form teratomas from the On the other hand, in the group of models with transplantation of iPS cells that underwent bone-differentiat-initial stage of differentiation induction. It has also been reported that the introduction of genes, such as Runx2 ing induction and irradiated with 2 Gy, none of 10 mice induced teratoma formation during the 4-week follow-up and peroxisome proliferator-activated receptor-γ (PPAR-γ)
